Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Genc: A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis.... (0.10 sec) 

A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis …


M Genc, PA Mardh - Annals of Internal Medicine, 1996 - Am Coll Physicians
Objective: To assess the cost-effectiveness of identifying and treating asymptomatic female carriers
of Chlamydia trachomatis. ... Design: Cost-effectiveness analysis based on previously reported
cohort analytic studies and average salaries and costs of medical care in Sweden.
Cited by 162 - Related articles - BL Direct - All 4 versions

Performance and cost-effectiveness of selective screening criteria for Chlamydia …


JM MARRAZZO, CL CELUM, SD HILLIS, D … - Sexually transmitted …, 1997 - journals.lww.com
The authors thank the following colleagues for contributions in the execution of this study:
Dr. Ann Haddix, Dr. Walter E. Stamm, Dr. Laura Koutsky, and Dr. Debra J. Mosure for their thoughtful
reviews of the manuscript; Ted Holzman, for assistance in computer-based analyses; the ...
Cited by 157 - Related articles - All 3 versions

Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program


J Paavonen, M Puolakkainen, M Paukku, H … - Obstetrics & …, 1998 - journals.lww.com
Objective: To perform a cost-benefit analysis of a Chlamydia trachomatis screening program
based on first-void urine testing of asymptomatic women using a polymerase chain reaction
(PCR) test. Methods: A decision tree was developed. Selected vari- ables based on ...
Cited by 87 - Related articles - BL Direct - All 6 versions

Screening for Chlamydia trachomatis in asymptomatic women attending family …

- annals.org
MR Howell, TC Quinn, CA Gaydos - Annals of internal medicine, 1998 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Background: Screening women
for Chlamydia trachomatis in family planning clinics is associated with a reduced ...
Cited by 132 - Related articles - BL Direct - All 5 versions

Effectiveness and efficiency of selective vs universal screening for chlamydial …


JW Sellors, L Pickard, A Gafni, CH … - Archives of Internal …, 1992 - archinte.highwire.org
Background.\p=m-\Sincechlamydial cervicitis is not associ- ated with specific complaints, screening
asymptomatic women is an important initiative to prevent pelvic inflam- matory disease and its
sequelae. Compared with universal screening, selective screeningis less costly but less ...
Cited by 57 - Related articles - All 5 versions

Screening women for Chlamydia trachomatis in family planning clinics: the cost- …


M Howell, TC Quinn, W Brathwaite, CA … - Sexually transmitted …, 1998 - journals.lww.com
The authors thank Terry Hogan, Samantha Johnson, Dr. JM Joseph, Pamela Nathanson, Nicole
Novak, Dr. Susan Hillis, and the numerous Region III/Baltimore City staff and clinicians who helped
make this study possible. The authors also thank Dr. Richard Moore for his thoughtful ...
Cited by 130 - Related articles - BL Direct - All 5 versions

An economic evaluation of screening for Chlamydia trachomatis in adolescent …


M Genc, L Ruusuvaara, PA Mardh - Jama, 1993 - Am Med Assoc
OBJECTIVE--To assess the cost-effectiveness of identifying asymptomatic carriers of Chlamydia
trachomatis among adolescent males. DESIGN--Cost-effectiveness analysis based on cohort
analytic studies previously reported and average salaries and costs of medical care in ...
Cited by 66 - Related articles - BL Direct - All 4 versions

The cost effectiveness of azithromycin for Chlamydia trachomatis infections in …


AC Haddix, SD Hillis, WJ Kassler - Sexually Transmitted Diseases, 1995 - journals.lww.com
The Cost Effectiveness of Azithromycin for Chlamydia trachomatis Infections in Women ANNE
C. HADDIX, PHD, SUSAN D. HILLIS, PHD, AND WILLIAM J. KASSLER, MD, MPH Background
and Objectives: Azithromycin, an approved sin- gle-dose therapy for cervical chlamydia ...
Cited by 76 - Related articles - BL Direct - All 3 versions

A cost-based decision analysis for Chlamydia screening in California family …


AI TRACHTENBERG, AE WASHINGTON, S … - Obstetrics & …, 1988 - journals.lww.com
A Cost-Based Decision Analysis for Chlamydia Screening in California Family Planning Clinics
ALAN I. TRACHTENBERG, MD, MPH, A. EUGENE WASHINGTON, MD, MSc, AND SANDRA
HALLDORSON, RN, MPH Antibody-based methods for the diagnosis of Chlamydia ...
Cited by 68 - Related articles - All 6 versions

Doxycycline compared with azithromycin for treating women with genital …

- annals.org
D Magid, JM Douglas, JS Schwartz - Annals of internal medicine, 1996 - Am Coll Physicians
Results: Under baseline assumptions, the azithromycin strategy incurred fewer major and minor
complications and was less expensive overall than the doxycycline strategy despite a higher
initial cost for acquiring antibiotic agents. In univariate sensitivity analyses, the ...
Cited by 108 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google